INSIGHTS ON DRUG DEVELOPMENT

• Spray Dried Dispersions In Controlled Release Formulations

  Integrating spray dried dispersions with CR strategies addresses poor drug solubility and the need for tailored release kinetics. Explore considerations to ensure stability and sustained supersaturation.

• The Role Of A Consulting Firm In The IND Process

  Navigate the complex IND process with expert guidance and discover how early FDA engagement can accelerate your path to clinical trials.

• Non Animal Origin Squalene For High-Risk Applications

  Explore an ethical and sustainable alternative to shark-derived squalene that is backed by robust data to deliver identical performance in vaccine formulations without environmental compromise.

• Cost And Scalability Key Drivers Of Expanded Gene Therapy Access

  Gene therapies are expanding beyond rare diseases, but high costs hinder access. Discover how innovations in viral vector manufacturing could make these breakthroughs more affordable.

• Spray Dried Biologics For Pulmonary Dosage Forms

  5/15/2026

  Spray drying creates stable inhalable biologic powders with controlled particle size, enabling effective lung delivery, improved stability, and scalable production for respiratory and systemic therapies.

• Navigating Drug Design In 'Beyond The Rule Of 5' Landscape

  6/17/2026

  New drug modalities are transforming treatment but bring new challenges. See how hybrid approaches that combine biologics and chemistry are redefining the design of innovative therapies.

• Advancing GLP-1 Analog Drug Development Using A Variety Of Techniques

  6/27/2025

  Discover how SEC-MALS reveals the aggregation behavior of GLP-1 analogs like semaglutide and liraglutide, which are critical for ensuring the stability, efficacy, and safety of peptide therapeutics.

• Assessment Of Compound Toxicity Effects With High-Content Imaging

  3/17/2025

  3D cellular models and bioprinting enhance drug safety predictions and offer precise spatial control. Explore an automated method for generating liver models to improve reproducibility and reliability in toxicity testing.

• Streamlining Biologics Development: Leveraging Small-Scale Studies For Greater Efficiency

  9/25/2025

  Uncover how a data-driven approach to small-scale studies not only accelerates development timelines but also enhances decision-making and resolves full-scale manufacturing challenges across diverse biologic modalities.